Navigation Links
BioNeutral Enters into Global Sales and Distribution Agreement with Raymond Associates to Expand Market for Military-Grade Ygiene(TM)
Date:3/15/2011

oved Hospital-Grade Ygiene™, will undoubtedly make a positive difference once put to use in our Military and VA hospitals and other healthcare facilities."

Founder and CEO of Raymond Associates, Kenneth R. Curley, is a West Point U.S. Military Academy graduate and distinguished Army officer veteran of over 20 years. Upon retirement in 1998, Mr. Curley was selected to serve within New York State government as the Director of Military Support, followed by Chief of Staff within the Division of Military and Naval Affairs. In 2003, Mr. Curley transitioned to the Country of Iraq, as the Deputy Director of Requirements Coordination in Baghdad and then as Chief of Staff Special Projects to the Coalition Provisional Authority.  In 2005, Raymond Associates supported the Emergency Response Efforts of Hurricane Katrina and Hurricane Rita.  Raymond Associates was founded in 2000, and has offices in New York, Florida, Baghdad, Iraq and the United Arab Emirates.

About Raymond Associates LLC Raymond Associates LLC is a Service Connected Disabled Veteran Owned Business that provides organizational development and executive management services in the United States, United Kingdom and the Middle East.  For more information, please visit http://raymondassociatesllc.com/.

About BioNeutral Group, Inc.Headquartered at the New Jersey Institute of Technology/EDC in Newark, BioNeutral Group, Inc., is a specialty technology-based life science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene™ and Ogiene™, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace.  BioNeutral's proprietary platform technology has been proven effective in surface, water and airbo
'/>"/>

SOURCE BioNeutral Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. BioNeutral Group Secures Three Initial Trial Orders for its Ogiene™ Odor Neutralizer & Multi-Purpose Cleaner Product Line
2. BioNeutral Group to Receive Economic Development Incentives
3. Kentucky Hospital Association Solutions Group Outlines Next Steps for BioNeutral Partnership
4. BioNeutrals Ygiene(TM) Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing
5. BioNeutral Groups CEO, Stephen Browand and Chief Scientist, Dr. Andrew Kielbania to Appear on WVOX 1460 AM In Focus Radio Show Hosted by Dr. Dan Miller
6. BioNeutrals Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing.
7. BioNeutrals Ygiene(TM) Hospital Grade Achieves World Class Independent Test Results in Killing Life Threatening Spores/Organisms
8. BioNeutrals Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase
9. BioNeutral Signs Agreement With a Non-profit for Long-Term Removal of Formaldehyde to Save 10,000 Mobile Homes in Louisiana
10. BioNeutrals Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
11. Pioneer® Surgical Technology, Inc. Enters the Biologics Extremities and Pelvis Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... zFlo Motion , a US leader in ... product from a new partner. STT-Systems has developed ... 15 years, with offerings in the optical-motion capture, 3D scanning, ... (inertial measurement unit), iSen, is opening eyes around the world. ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Diagenode, ... such as the Bioruptor® and complete solutions for ... for chromatin immunoprecipitation, alleviating the need for manual ... controls needed for ChIP of histones or transcription ...
(Date:1/22/2015)... , a precision medicine software company that has developed a ... genomic, imaging and other biomedical data in research and clinical ... CEO of Aspera, an IBM Company, to its board as ... "We are pleased to welcome Michelle to ...
(Date:12/24/2014)... DALLAS and NEW YORK , ... a biopharmaceutical company advancing patient care in critical areas, announced ... of common stock, and warrants to purchase up to an ... of $4.00 per share and $.01 per warrant.  The warrants ...
Breaking Biology Technology:3D Motion Capture Just Got Easy 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2GenoSpace Expands Board with Appointment of Michelle Munson 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... 2011 The Plasma Protein Therapeutics Association (PPTA) ... to Orphan Drugs Act ( H.R. 2672 ) and ... drugs and therapies that treat patients with rare diseases by ... who rely on plasma protein therapies are coping with a ...
... NOVATO, Calif., July 28, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: ... GALNS Phase 1/2 extension study (MOR-100) in which patients have ... originally enrolled in the initial Phase 1/2 study of GALNS ... (MOR-100).  In the MOR-100 study, patients were treated at a ...
... fight over deficit reform continues to drag on in Washington, ... across the region to fight to save a critical sector ... a victim of short-sighted cuts. "Proposed cuts to ... to seniors, but would require seniors to pay more for ...
Cached Biology Technology:PPTA Praises Legislation That Protects the Treatment of Rare Diseases 2BioMarin Provides Update on GALNS Phase 1/2 Extension Study (MOR-100) 2BioMarin Provides Update on GALNS Phase 1/2 Extension Study (MOR-100) 3BioMarin Provides Update on GALNS Phase 1/2 Extension Study (MOR-100) 4BioMarin Provides Update on GALNS Phase 1/2 Extension Study (MOR-100) 5BioMarin Provides Update on GALNS Phase 1/2 Extension Study (MOR-100) 6Biotech Group Warns Proposed Medicare Cuts Could Hurt Critical Sector of New England Economy 2
(Date:12/24/2014)... its launch in December 2014, the 1U™ app ... trying to remember their usernames and passwords through replacing the ... To assist people who have struggled to remember usernames and ... and focuses on redefining identity, announced today that it is ...
(Date:12/19/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) has ... America Perimeter Security Systems Market" report to their offering. ... North American perimeter security market is estimated to grow at ... U.S. market holds a larger share in this market, ...
(Date:12/17/2014)... SM announced today its completion of a Good ... current U.S. Food and Drug Administration (FDA) regulations. This ... smart phone application trials utilizing the highest principles for ... determined to improve global healthcare access, quality, and delivery ...
Breaking Biology News(10 mins):1U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... Twenty years after its introduction, gene therapy still holds great ... viruses such as human immunodeficiency syndrome (HIV). But scientists have ... system that is capable of delivering therapeutic payloads to specific ... researchers in the USC Viterbi School of Engineering may be ...
... can safely drive while talking on their cell phones. Vanderbilt ... when it comes to handling two things at once, your ... it that with our incredibly complex and sophisticated brain, with ... a thousand times a second, we still have such a ...
... the National Institutes of Health have developed an experimental ... infected with cytomegalovirus (CMV)—a common virus that can also ... who were infected in early fetal life. , Estimates ... each year at about 40,000, and there is no ...
Cached Biology News:Can engineered immune cells stop AIDS? 2Can engineered immune cells stop AIDS? 3Neural bottleneck found that thwarts multi-tasking 2Neural bottleneck found that thwarts multi-tasking 3Experimental vaccine given during pregnancy reduces stillbirths from common virus 2Experimental vaccine given during pregnancy reduces stillbirths from common virus 3
...
... a-Amylase is an enzyme that catalyzes ... of maltose, maltotriose, and dextrins. The,level ... the human body is of,clinical significance ... including,pancreatitis and diabetes; plant and microbial ...
... Jouan MSC series of Class II ... conditions and certification to the world's ... ensures that the cabinets cannot be ... Natural lighting, low noise and arm ...
... Fluoroskan Ascent FL is ... and luminometric measurement technologies ... list of advanced features ... Luminoskan Ascent. Fluoroskan Ascent ...
Biology Products: